Feed PBLA
PB
Panbela Therapeutics, Inc.
PBLA · OTC
$0.01 +0.00% (+$0.00)
1M +122.00%
Market Cap $53.9K
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$100.95
909359.5% upside
Current Price
$0.011
Undervalued Fair Value Overvalued
Valuation
-
N/A P/B N/A
P/FFO N/A
P/E N/A
Growth
-
N/A Book val. growth N/A
FCF growth N/A
EPS growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
0 /100
Poor ROA 0.00%
Asset turnover 0.00x
ROIC 0.00%
Debt
79 /100
Low Int. coverage 81.28x
Net debt/EBITDA -0.05x
Current ratio 0.25x
Stability
1 /100
Unstable EPS volatility 233.84%
Profitable years 0
Beta 1.88x
Ask StockBot about PBLA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jennifer K. Simpson
Employees
7
Headquarters
Waconia
Upcoming events
12 AUG
Earnings
Upcoming earnings report